View Mobile Friendly Conference List »

Setting new standards in information exchange for the pharmaceutical and biotech industry

Blog

Consortia-pedia Author, Mark Lim, PhD of Faster Cures Joins Dpharm Speaking Faculty


  • July 7, 2014

  • We are pleased to welcome Mark Lim, PhD of Faster Cures and author of the Consortia-pedia project to DPharm.  Mark will provide highlights on the project to help us better understand the approaches that a wide range of consortia have adopted to bring together non-traditional partners with a shared R&D goal. Mark will also address challenges that some consortia are facing as well as opportunities to further collaboration.

    More info on the report:

    http://www.fastercures.org/reports/view/39

    About Mark:
    MLim
    Mark D. Lim is the medical research innovation associate director at FasterCures and also serves on the scientific advisory board of the Quebec Consortium for Drug Discovery. Prior to joining FasterCures, Lim served a supporting role as the chief of technical staff at DARPA’s Defense Sciences Office on a biomedical program that had efforts in new diagnostic and vaccine capabilities. He was the deputy program director for the Program for Innovative Molecular Analysis Technologies, an extramural funding program at the National Cancer Institute (NCI), and also served as an AAAS Science and Technology Policy Fellow at the NCI Office of Biorepositories and Biospecimen Research. Lim received his doctorate in chemistry at University of California, Santa Barbara and completed an NCI-funded postdoctoral fellowship in cancer nanotechnology at University of California, San Francisco and University of California, Berkeley. He has authored or co-authored 23 publications and book chapters on biospecimen quality challenges, federal funding opportunities for innovation, nanotechnology, and inorganic chemistry.